Meet the investigator: Daniel D. Billadeau, Ph.D.
At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Daniel D. Billadeau, Ph.D., an oncology researcher at Mayo Clinic in Rochester, Minnesota, talks about his work investigating pancreatic cancer. Dr. Billadeau is also a principal investigator of the Mayo Clinic Pancreatic Cancer SPORE.
Related
This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.
Related Posts
They identified a cell-signaling protein that drives pancreatic cancer cell growth that could be a potential therapeutic target.
Researchers built a highly accurate artificial intelligence model for fully automated cancer detection, including small and otherwise difficult-to-detect tumors.
Rita Krueger shares the lessons she has learned from her experience with pancreatic cancer diagnosis, treatment and survivorship.